Dynamic human gut microbiome and immune shifts during an immersive psychosocial intervention program
- PMID: 39701328
- PMCID: PMC11903166
- DOI: 10.1016/j.bbi.2024.12.027
Dynamic human gut microbiome and immune shifts during an immersive psychosocial intervention program
Abstract
Background: Although depression is a leading cause of disability worldwide, the pathophysiological mechanisms underlying this disorder-particularly those involving the gut microbiome-are poorly understood.
Method: To investigate, we conducted a community-based observational study to explore complex associations between changes in the gut microbiome, cytokine levels, and depression symptoms in 51 participants (Mage = 49.56, SD = 13.31) receiving an immersive psychosocial intervention. A total of 142 multi-omics samples were collected from participants before, during, and three months after the nine-day inquiry-based stress reduction program.
Results: Results revealed that depression was associated with both an increased presence of putatively pathogenic bacteria and reduced microbial beta-diversity. Following the intervention, we observed reductions in neuroinflammatory cytokines and improvements in several mental health indicators. Interestingly, participants with a Prevotella-dominant microbiome showed milder symptoms when depressed, along with a more resilient microbiome and more favorable inflammatory cytokine profile, including reduced levels of CXCL-1.
Conclusions: These findings reveal a potentially protective link between the Prevotella-dominant microbiome and depression, as evidenced by a reduced pro-inflammatory environment and fewer depressive symptoms. These insights, coupled with observed improvements in neuroinflammatory markers and mental health from the intervention, may highlight potential avenues for microbiome-targeted therapies for managing depression.
Keywords: CXCL-1; Gut microbiome; Neuroinflammation; Psychosocial intervention.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: M.P.S. is a co-founder and scientific advisor for Crosshair Therapeutics, Exposomics, Filtricine, Fodsel, Iollo, InVu Health, January AI, Marble Therapeutics, Mirvie, Next Thought AI, Orange Street Ventures, Personalis, Protos Biologics, Qbio, RTHM, SensOmics. M.P.S. serves as a scientific advisor for Abbratech, Applied Cognition, Enovone, Jupiter Therapeutics, M3 Helium, Mitrix, Neuvivo, Onza, Sigil Biosciences, TranscribeGlass, WndrHLTH, Yuvan Research. M.P.S. is a co-founder of NiMo Therapeutics. M.P.S. is an investor and scientific advisor of R42 and Swaza. M.P.S. is an investor in Repair Biotechnologies. A.B.G. is a co-founder of Arben Ventures and Xthena Partners. B.R. is a co-founder of Arben Ventures, Enovone, and an advisor to Bexson and Northstar Care. After data collection was complete, as well as after most data analysis was completed, A.B.G. and B.R. co-founded what was formerly InquiryRx with Byron Katie, but ultimately decided not to continue the venture. Trudy Green was the 100 % owner of InquiryRx. Byron Katie lectured in Stanford BIOS 237, a class co-taught by A.B.G. and M.P.S. and spoke at the Stanford Mental Healthcare Innovations Summit. At the time of the initial publication of this article, the Academic Incubator Fund, managed by Arben Ventures, of which A.B.G. and B.R. are co-founders and managing partners, is an investor in 36 companies—namely, Bloch Quantum Imaging Solutions, Elemind Technologies, North-StarCare, Mercy BioAnalytics, Othership, Superbio.ai, Empo Health, Kelso Health, Acta Pharmaceuticals, Enovone, Superhumn, Parallel Health, Mitrix Bio, Bexson Biomedical, Allia Health, Glyphic Biotechnologies, RTHM, QBio, NextThought AI, ReMinded, Lynx Tech, Firefly VR-P, Amira Health, Imago Systems, SeeMedX, Vertility Health, OnFirm, ModoScript, Outro Health, Concha Labs, The Natural Nipple, Navan Technologies, TranscribeGlass, Dognosis, MoveJoy, and Kangaroo Bio–and an advisor to Bloch Quantum Imaging Solutions, Elemind Technologies, Allia Health, and SeeMedX. The remaining authors do not have any conflicts of interest with respect to this work.
Figures




Update of
-
Dynamic Human Gut Microbiome and Immune Shifts During an Immersive Psychosocial Therapeutic Program.bioRxiv [Preprint]. 2024 Jun 27:2024.06.26.600881. doi: 10.1101/2024.06.26.600881. bioRxiv. 2024. Update in: Brain Behav Immun. 2025 Mar;125:428-443. doi: 10.1016/j.bbi.2024.12.027. PMID: 38979211 Free PMC article. Updated. Preprint.
Similar articles
-
Dynamic Human Gut Microbiome and Immune Shifts During an Immersive Psychosocial Therapeutic Program.bioRxiv [Preprint]. 2024 Jun 27:2024.06.26.600881. doi: 10.1101/2024.06.26.600881. bioRxiv. 2024. Update in: Brain Behav Immun. 2025 Mar;125:428-443. doi: 10.1016/j.bbi.2024.12.027. PMID: 38979211 Free PMC article. Updated. Preprint.
-
Psychological therapies for treatment-resistant depression in adults.Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2. Cochrane Database Syst Rev. 2018. PMID: 29761488 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Specialist breast care nurses for support of women with breast cancer.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3. Cochrane Database Syst Rev. 2021. PMID: 34559420 Free PMC article.
-
Psychological therapies for women who experience intimate partner violence.Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD013017. doi: 10.1002/14651858.CD013017.pub2. Cochrane Database Syst Rev. 2020. PMID: 32608505 Free PMC article.
Cited by
-
Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.Curr Issues Mol Biol. 2025 Jun 26;47(7):489. doi: 10.3390/cimb47070489. Curr Issues Mol Biol. 2025. PMID: 40728958 Free PMC article. Review.
References
-
- Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V, 2012. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885–1895. - PubMed
-
- Allan RD, Johnston GA, 1983. Synthetic analogs for the study of GABA as a neurotransmitter. Med. Res. Rev 3, 91–118. - PubMed
-
- Artigas F, 2013. Serotonin receptors involved in antidepressant effects. Pharmacol. Ther 137, 119–131. - PubMed
-
- Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Meta HITC, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Merieux A, Melo Minardi R, M’Rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P, 2011. Enterotypes of the human gut microbiome. Nature 473, 174–180. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical